readthroughSign in
CompanyLEGNNasdaqSomerset, NJ

Legend Biotech Corp

Legend Biotech develops CAR-T cell therapies, including CARVYKTI for relapsed or refractory multiple myeloma, which it markets with Johnson & Johnson.

424B3Nov 12Latest SEC filing
Nov 10Latest story